Q4 2015
Released Mar 10, 2016, after the close
10-K filed Mar 10, 2016, 70 days after period end · 0001144204-16-087232
Q4 2015 · 10-K
Revenue—
Net Income-$4.63M-$4.63M N/M vs Q4 2014N/M vs Q3 2015
EPS Diluted-$0.25-$0.25 no prior Q4 2014 on fileN/M vs Q3 2015
Operating Income-$4,696,098N/M
Operating Cash Flowderived-$2,911,627N/M
Free Cash Flowderived-$2,911,626N/M
What the release said
The release
Same quarter
| Metric | Q4 2015 | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$4.63M | -$4.04M | -$4.39M | $5.02M |
| EPS Diluted | -$0.25 | — | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR